|
|
| Drug Discovery US 2025: Innovation Takes the Stage in San Diego | Get ready, San Diego! Drug Discovery US 2025 lands this October 2nd - 3rd, bringing world-leading experts in drug product development and delivery to the West Coast’s scientific hub. Dive into presentations, panels, and roundtables—including a featured session on degraders and molecular glues, with case studies on cutting-edge discovery platforms. Cap off the day at our Innovations & Breakthroughs Under the Stars Garden Party. |
|
|
|
|
By Shikha Gianchandani, Gaja Gasiorek, and Pooja Goyal, Lifescience Dynamics | The treatment landscape for psoriatic arthritis (PsA) is evolving rapidly, with data presented at EULAR 2025 signaling a new chapter in disease management with the emergence of a selective tyrosine kinase 2 (TYK2) inhibitor. | |
|
|
|
|
|
| Mitigating Hidden Risks: Extractables And Leachables | Case Study | By Christopher Wittum, Cambrex | Everything from glass or plastic bottles to the ink used in labels can leach unwanted contaminants. The first challenge chemists address is to narrow the focus on the most likely suspects. |
|
|
|
|
| Liquid Biopsy-Based Detection Of PIK3CA Mutations From cfDNA | Application Note | By Simon Hertlein, Annika Voets, Colin Donohoe, and Ellen Bruske, QIAGEN | Discover how ultra-sensitive digital PCR workflows use an innovative system to enable precise detection of rare PIK3CA mutations in cfDNA and advance personalized cancer treatment. |
|
|
|
|
|
